Interstitial Lung Abnormalities in a CT Lung Cancer Screening Population: Prevalence and Progression Rate
Abstract
Interstitial lung abnormality was found in about 10% of lung cancer screening participants.
Purpose
To determine the prevalence of interstitial lung abnormalities (ILAs) at initial computed tomography (CT) examination and the rate of progression of ILAs on 2-year follow-up CT images in a National Lung Screening Trial population studied at a single site.
Materials and Methods
The study was approved by the institutional review board and informed consent was obtained from all participants. Image review for this study was HIPAA compliant. We reviewed the CT images of 884 cigarette smokers who underwent low-dose CT at a single site in the National Lung Screening Trial. CT findings were categorized as having no evidence of ILA, equivocal for ILA, or ILA. We categorized the type of ILA as nonfibrotic (ground-glass opacity, consolidation, mosaic attenuation), or fibrotic (ground glass with reticular pattern, reticular pattern, honeycombing). We evaluated the temporal change of the CT findings (no change, improvement, or progression) of ILA at 2-year follow-up. A χ2 with Fisher exact test or unpaired t test was used to determine whether smoking parameters were associated with progression of ILA at 2-year follow-up CT.
Results
The prevalence of ILA was 9.7% (86 of 884 participants; 95% confidence interval: 7.9%, 11.9%), with a further 11.5% (102 of 884 participants) who had findings equivocal for ILA. The pattern was fibrotic in 19 (2.1%), nonfibrotic in 52 (5.9%), and mixed fibrotic and nonfibrotic in 15 (1.7%) of the 86 participants with ILA. The percentage of current smokers (P = .001) and mean number of cigarette pack-years (P = .001) were significantly higher in those with ILA than those without. At 2-year follow-up of those with ILA (n = 79), findings of nonfibrotic ILA improved in 49% of cases and progressed in 11%. Fibrotic ILA improved in 0% and progressed in 37% of cases.
Conclusion
ILA is common in cigarette smokers. Nonfibrotic ILA improved in about 50% of cases, and fibrotic ILA progressed in about 37%.
© RSNA, 2013
References
- 1 . Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161(2 Pt 1):646–664.
- 2 . American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165(2):277–304. [Published correction appears in Am J Respir Crit Care Med 2002;166(3):426.]
- 3 . Identification of early interstitial lung disease in smokers from the COPDGene Study. Acad Radiol 2010;17(1):48–53.
- 4 . Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med 2011;364(10):897–906.
- 5 . Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study. Chest 2010;137(1):129–137.
- 6 . The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994;150(4):967–972.
- 7 . Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure. Am J Respir Crit Care Med 1994;150(3):670–675.
- 8 . Interstitial lung diseases: an epidemiological overview. Eur Respir J Suppl 2001;32:2s–16s.
- 9 . Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006;174(7):810–816.
- 10 . Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology 1989;171(1):111–116.
- 11 . Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001;164(2):193–196.
- 12 . Accuracy of high-resolution CT in diagnosing lung diseases. AJR Am J Roentgenol 1998;170(6):1507–1512.
- 13 . Other smoking-affected pulmonary diseases. Clin Chest Med 2000;21(1):121–137, ix.
- 14 . Interstitial lung diseases in a lung cancer screening trial. Eur Respir J 2011;38(2):392–400.
- 15 . The National Lung Screening Trial: overview and study design. Radiology 2011;258(1):243–253.
- 16 . Hypersensitivity pneumonitis: spectrum of high-resolution CT and pathologic findings. AJR Am J Roentgenol 2007;188(2):334–344.
- 17 . Neglectable benefit of searching for incidental findings in the Dutch-Belgian lung cancer screening trial (NELSON) using low-dose multidetector CT. Eur Radiol 2007; 17(6):1474–1482.
- 18 . Screening for lung cancer using low dose CT scanning. Thorax 2004;59(3):237–241.
- 19 . Lung cancer screening with CT: Mayo Clinic experience. Radiology 2003;226(3):756–761.
- 20 . Respiratory bronchiolitis-interstitial lung disease: long-term outcome. Chest 2007; 131(3):664–671.
- 21 . Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 1974;291(15):755–758.
- 22 . Lung parenchymal changes secondary to cigarette smoking: pathologic-CT correlations. Radiology 1993;186(3):643–651.
- 23 . CT findings in a proved case of respiratory bronchiolitis. AJR Am J Roentgenol 1993;161(1):44–46.
- 24 . Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc 1989;64(11):1373–1380.
- 25 . Respiratory bronchiolitis, respiratory bronchiolitis-associated interstitial lung disease, and desquamative interstitial pneumonia: different entities or part of the spectrum of the same disease process? AJR Am J Roentgenol 1999;173(6):1617–1622.
- 26 . High resolution CT in respiratory bronchiolitis-associated interstitial lung disease. J Comput Assist Tomogr 1993;17(1):46–50.
- 27 . Respiratory bronchiolitis-associated interstitial lung disease: radiologic features with clinical and pathologic correlation. J Comput Assist Tomogr 2002;26(1):13–20.
- 28 . Changes in HRCT findings in patients with respiratory bronchiolitis-associated interstitial lung disease after smoking cessation. Eur Respir J 2007;29(3):453–461.
- 29 . Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997; 155(1):242–248.
- 30 . Lung morphology in the elderly: comparative CT study of subjects over 75 years old versus those under 55 years old. Radiology 2009;251(2):566–573.
- 31 . Subclinical interstitial lung disease: why you should care. Am J Respir Crit Care Med 2012;185(11):1147–1153.
- 32 . Low-dose high-resolution CT of lung parenchyma. Radiology 1991;180(2):413–417.
Article History
Received April 10, 2012; revision requested May 31; revision received September 7; accepted October 5; final version accepted January 14, 2013.Published online: Aug 2013
Published in print: Aug 2013